genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Cancer
Changing Carcinogenic Cells in the Lungs with Novel Technology
Gastrointestinal Disorders
GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen
Cancer
Molecular Anchor Creates More Effective CAR T Immunotherapies
Cancer
White House Continues Dedication to “End Cancer as We Know It”
Cancer
Molecular Pathways Used by Metastatic Cancer Cells Uncovered
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
OMICs
Reflections on the Double Helix’s Platinum Anniversary
Artificial Intelligence
AI and Computational Design Advance Protein Engineering
Bioprocessing
In Pursuit of Rare, Subtle, and Fleeting Post-Translational Modifications
Infectious Diseases
Tripledemic Rouses Vaccine Developers and Variant Trackers
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
RNA
Antisense
Antisense
Antisense
Gene Silencing
lncRNA
miRNA
mRNA
RNAi
shRNA
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Antisense
Stoked About ASOs: Stoke Therapeutics Treats Rare CNS Diseases With RNA-Based Medicines
Antisense
Targeting LINE-1 RNA Might Prove Therapeutic for Premature Aging Syndromes
Antisense
n-Lorem Makes Ultrarare Disease Treatment Personal
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Antisense
DNA/DNA Heteroduplex Construct Suppresses Gene Expression
Antisense
Potential Prion Disease Treatment Found in Antisense Therapy
Antisense
NeuBase Sets a Course for the Clinic
Antisense
Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B
Antisense
Injectable RNA Therapy Dramatically Improves Vision in Child Blindness
Antisense
Fluorescent Muscular Dystrophy Mouse Lights Up Potential Antisense Oligo Drugs
Antisense
Got Milk? Roche to Apply PureTech Exosomes Platform in $1B+ Collaboration
Antisense
Roche Licenses Ionis’ Antisense HD Therapy Following Groundbreaking Trial
Antisense
Biogen Pays Ionis $10M as Phase I/IIa Trial Launched for Alzheimer’s...
Antisense
Ionis Antisense Drug Meets Primary Endpoints in Phase III FAP Study
Antisense
Ionis, Ribo Partner to Develop RNA-Targeted Therapeutics in China
1
2
3
...
5
Page 1 of 5
Scroll Up
Login
Subscribe
